Executive Summary
An extraordinary single-day surge of 51 Item 5.02 8-K filings on February 17, 2026, across diverse US sectors signals a potential nationwide boardroom reshuffle, possibly tied to macroeconomic pressures, performance issues, or executive market dynamics. All filings exhibit neutral sentiment with no disclosed quantitative enriched data such as YoY/QoQ trends, insider trading activity, forward-looking guidance, capital allocation details, or financial ratios, limiting deep metric comparisons but highlighting pervasive governance opacity. Approximately 70% (36/51) carry low-to-medium risk, with 1 high-risk case (Willamette Valley Vineyards director departure); average materiality 4.5/10, elevated to 5-6/10 in 20 companies like Hyatt, Match Group, and Marriott Vacations. Sector clusters emerge: Biotech (6+ firms including Sana, Cingulate, Annexon), Hospitality (3: Hyatt, Royal Caribbean, Marriott Vacations), Tech/Semicon (7+: MaxLinear, Cognex, Akamai, AMD), Industrials/Energy (10+). Over 25 filings include Item 7.01 Regulation FD disclosures, suggesting material updates potentially linked to changes, while absence of period comparisons prevents growth/margin trend synthesis. Portfolio implications: Heightened short-term volatility; prioritize monitoring for follow-on details revealing appointments (bullish) vs. resignations (bearish), with hospitality and biotech as focal points for relative underperformance risks.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from February 12, 2026.
Investment Signals(12)
- Akamai Technologies Inc↓(BULLISH)▲
Low risk officer change (materiality 5/10), potential leadership strengthening in cloud/tech sector, Item 9.01 exhibits filed
- Solaris Energy Infrastructure Inc↓(BULLISH)▲
Medium risk but explicit opportunity note for leadership expertise addition if appointment, energy services focus (materiality 5/10)
- Cingulate Inc↓(BULLISH)▲
Item 7.01 Reg FD + Item 5.02 signals potential positive succession/expertise boost in biotech, materiality 6/10 despite medium risk
- Falcon's Beyond Global Inc↓(BULLISH)▲
Medium risk with noted opportunity for leadership strengthening, entertainment/tech with Item 7.01 (materiality 5/10)
- Match Group Inc↓(BULLISH)▲
High materiality 6/10 officer change + Item 7.01 Reg FD in dating/tech, routine governance potentially positive (medium risk)
- Willamette Valley Vineyards Inc↓(BEARISH)▲
Director departure explicitly flagged, high risk in food/bev sector (materiality 6/10), signals potential instability
- Sana Biotechnology Inc↓(BEARISH)▲
Medium risk uncertainty in leadership stability, biotech with Item 7.01 but no details disclosed (materiality 5/10)
- Rockwell Automation Inc↓(BEARISH)▲
Medium risk officer change in industrials, lack of details on position/reason (materiality 5/10), governance opacity
- Hyatt Hotels Corp↓(BEARISH)▲
Medium risk, high materiality 6/10 hospitality change with Item 7.01, undisclosed details raise execution concerns
- Royal Caribbean Cruises Ltd↓(BEARISH)▲
Medium risk officer change in cruises/hospitality cluster (materiality 4/10), potential sector-wide turnover signal
- AMD(BEARISH)▲
Low risk routine disclosure in key semiconductor, but cluster with MaxLinear/Cognex raises sector reshuffle concerns (materiality 4/10)
- Redwire Corp↓(BEARISH)▲
Medium risk, high materiality 6/10 aerospace/defense change with Item 8.01 other events, undisclosed impacts
Risk Flags(10)
- ▼
Sole high-risk filing with explicit director departure, potential governance instability (materiality 6/10)
- Sana Biotechnology/Leadership Uncertainty↓[MEDIUM RISK]▼
Medium risk from unspecified officer details, biotech stability concerns with Item 7.01
- Rockwell Automation/Officer Change↓[MEDIUM RISK]▼
Medium risk, no position/reason disclosed in industrial automation leader (materiality 5/10)
- Hyatt Hotels/Undisclosed Details↓[MEDIUM RISK]▼
Medium risk hospitality with high materiality 6/10, Item 7.01 opacity amid sector cluster
- Marriott Vacations Worldwide/Instability Signal↓[MEDIUM RISK]▼
Medium risk, materiality 6/10, unknown appointment vs. resignation in hospitality turnover wave
- Cingulate Inc/Unregistered Sales↓[MEDIUM RISK]▼
Medium risk Item 5.02 + Item 3.02 equity dilution potential alongside biotech change
- Earth Science Tech/Governance Opacity↓[MEDIUM RISK]▼
Medium risk, materiality 6/10 health/tech change with Item 7.01 undisclosed material info
- National Healthcare Corp/Sudden Change↓[MEDIUM RISK]▼
Medium risk, materiality 6/10 healthcare with potential instability from undisclosed reasons
- Redwire Corp/Other Events↓[MEDIUM RISK]▼
Medium risk Item 5.02 + Item 8.01, high materiality 6/10 in aerospace signals broader issues
- Skillz Inc/Uncertainty↓[MEDIUM RISK]▼
Medium risk gaming/tech change with no details, potential leadership void (materiality 5/10)
Opportunities(10)
- Akamai Technologies/New Expertise↓(OPPORTUNITY)◆
Low risk Item 5.02 suggests potential positive appointment in cloud security, monitor for tech outperformance
- Cingulate Inc/Succession Play↓(OPPORTUNITY)◆
Explicit opportunity for expertise addition in biotech, Item 7.01 + high materiality 6/10 for turnaround
- Solaris Energy Infrastructure/Leadership Boost↓(OPPORTUNITY)◆
Noted opportunity if appointment, medium risk energy services with Item 9.01 details
- Match Group/Reg FD Catalyst↓(OPPORTUNITY)◆
Item 7.01 alongside high materiality 6/10 change in consumer tech, potential strategic refresh
- Hyatt Hotels/Strategic Refresh↓(OPPORTUNITY)◆
High materiality 6/10 hospitality pivot via officer change + Item 7.01, relative to sector peers
- Boston Beer Co/Routine Upgrade↓(OPPORTUNITY)◆
Low risk bev/consumer change (materiality 3/10), opportunity in stable governance evolution
- MarketAxess Holdings/Governance Evolution↓(OPPORTUNITY)◆
Low risk fintech change (materiality 3/10), potential efficiency gains post-update
- Carpenter Technology/Industrial Play↓(OPPORTUNITY)◆
Low risk with Item 7.01, materiality 4/10 materials sector for leadership optimization
- Falcon's Beyond Global/Entertainment Upside↓(OPPORTUNITY)◆
Noted leadership strengthening potential, medium risk with Item 7.01 (materiality 5/10)
- CPI Card Group/Payments Stability↓(OPPORTUNITY)◆
Low risk routine disclosure (materiality 3/10), fintech opportunity amid cluster
Sector Themes(6)
- Biotech Leadership Flux◆
6+ filings (Sana, Cingulate, CNS Pharma, Annexon, Exicure, ImageneBio) all medium risk avg materiality 5/10, undisclosed changes amid R&D pressures; watch for innovation acceleration or instability
- Hospitality Turnover Wave◆
3 majors (Hyatt, Royal Caribbean, Marriott Vacations) medium risk/mat 5-6/10 with Item 7.01 clusters, potential post-recovery executive realignment vs. consumer spending slowdown
- Tech/Semicon Reshuffle◆
7+ (MaxLinear, Cognex, Akamai, Match Group, AMD, Skillz) low-medium risk avg materiality 5/10, single-day spike suggests talent competition or AI-driven board refreshes
- Industrials/Energy Opacity◆
10+ (Rockwell, Trinity, Graham, Solaris, AEP, NorthWestern, Carpenter) low-medium risk, uniform lack of details flags potential capex/M&A prep amid cycle shifts
- Financial/Insurance Clusters◆
6+ (Columbia Financial, Goosehead, Travelers, Arbor Realty, World Acceptance, MarketAxess) varying risk/mat 4-6/10, changes tied to rate environment or regulatory adaptation
- Reg FD Materiality Overlay◆
25+/51 filings include Item 7.01, elevating average materiality by 1-2 points; implies coordinated positive/negative updates hidden in exhibits across sectors
Watch List(8)
High risk director departure; monitor for follow-on 8-K naming replacement or board impacts, potential stock dip
High materiality 6/10 + Item 7.01; watch exhibits/follow-ups for CEO/CFO specifics amid hospitality cluster, by Feb 24
- AMD/Officer Role Clarity👁
Low risk semicon leader in tech cluster; track subsequent filings for position/reason, insider activity post-Feb 17
Medium risk biotech with Item 7.01; monitor for guidance or performance links in next quarterly
High materiality 6/10 tech + Reg FD; watch earnings call for change context, potential M&A tie-in
High materiality 6/10 aerospace + other events; follow for quantitative impacts or capital allocation updates
- Biotech Cluster (Cingulate, Annexon, Exicure)/Trial Catalysts👁
3+ medium risk; scan for forward-looking tied to changes, upcoming FDA/earnings
- Hospitality Trio (Royal Caribbean, Marriott Vacations)/Travel Trends👁
Medium risk cluster; monitor Q1 bookings metrics post-change for relative performance
Filing Analyses(51)
17-02-2026
MaxLinear, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, appointment or resignation, reasons, or quantitative impacts are disclosed.
- ·Event date: February 17, 2026
- ·Filing accession number: 0001288469-26-000017
- ·File size: 210 KB
17-02-2026
Sana Biotechnology, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or timing are explicitly stated. No quantitative data, performance metrics, or further governance implications are mentioned in the provided filing information.
- ·Accession Number: 0001193125-26-053294
- ·Filing size: 346 KB
- ·Event date aligns with filing date (2026-02-17), suggesting prompt disclosure within SEC 4-business-day requirement
17-02-2026
Rockwell Automation, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054744), disclosing an officer change under Item 5.02 related to departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative terms are disclosed.
17-02-2026
MGP Ingredients Inc filed an 8-K on February 17, 2026 (AccNo: 0000835011-26-000006), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including names, titles, reasons for changes, or any quantitative impacts are NOT_DISCLOSED. No positive or negative metrics, financial data, or further context provided.
17-02-2026
JFB Construction Holdings filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006871), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics are disclosed. Sector information is not specified.
- ·Filing date: 2026-02-17
- ·Accession Number: 0001493152-26-006871
- ·File size: 208 KB
- ·Event type: Officer Change
17-02-2026
Hyatt Hotels Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals involved, appointment or resignation status, reasons for the change, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events were mentioned in the provided filing information.
17-02-2026
WESCO INTERNATIONAL INC filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. This appears to be a routine governance disclosure with no quantified impacts mentioned.
17-02-2026
Trinity Industries Inc filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or impacts are disclosed.
17-02-2026
Science Applications International Corp filed an 8-K on 2026-02-17 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or market impacts are mentioned.
17-02-2026
Columbia Financial, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or impacts are provided in the available information. This is a required SEC disclosure for material leadership events, but lacks quantitative or qualitative context.
17-02-2026
Cognex Corp filed an 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists financial statements and exhibits. Specific details including key position affected, appointment or resignation status, reasons for change, timing, names, and any quantitative data are NOT_DISCLOSED.
17-02-2026
Gemini Space Station, Inc. filed an 8-K on 2026-02-17 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential compensatory arrangements, under Item 5.02. No specific details such as the key position affected, appointment or resignation status, reasons for the change, board impacts, financial metrics, or quantitative data are provided. The filing is informational with no disclosed positive or negative performance indicators.
17-02-2026
Cingulate Inc. filed an 8-K on 2026-02-17 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details including affected positions, names, appointment or resignation status, reasons, and any financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events were mentioned.
17-02-2026
Graham Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-053140), reporting under Item 5.02 on departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 7.01 on Regulation FD disclosure; and Item 9.01 on financial statements and exhibits. Specific details including officer names, positions, reasons for change, timing, or any financial metrics are NOT_DISCLOSED. No quantitative data, performance comparisons, or scheduled events are mentioned.
17-02-2026
CNS Pharmaceuticals, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001683168-26-001066), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any compensatory arrangements are disclosed. No quantitative metrics, financial data, or performance comparisons are provided.
17-02-2026
Bowman Consulting Group Ltd. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, timing, or any quantitative financial metrics are disclosed. This appears to be a routine governance disclosure without additional performance data.
17-02-2026
CPI Card Group Inc. filed an 8-K on 2026-02-17 (AccNo: 0001104659-26-015886, Size: 140 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or financial implications are explicitly stated in the provided filing summary. No quantitative metrics, performance comparisons, or other events are mentioned.
- ·Event date: 2026-02-17
- ·Source: us_sec
- ·Sector: NOT_DISCLOSED
17-02-2026
Royal Caribbean Cruises Ltd filed a Form 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, reason for change, timing, or any quantitative metrics are provided.
17-02-2026
Earth Science Tech, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.
17-02-2026
Marriott Vacations Worldwide Corp filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer's name, title, reason for departure or appointment, effective date, or internal/external status are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the available information.
17-02-2026
VirTra, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001493152-26-006967), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals, appointment/resignation status, reasons, timing, or governance implications were provided. No quantitative data, financial metrics, or scheduled events were mentioned.
17-02-2026
Match Group, Inc. filed an 8-K on February 17, 2026 (AccNo: 0000891103-26-000022, Size: 162 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.
- ·Filing date: 2026-02-17
- ·Source: us_sec
- ·Sector: NOT_DISCLOSED
17-02-2026
MDWerks, Inc. filed an 8-K on February 17, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. Specific details including names, positions, reasons for changes, timing, or any quantitative data are NOT_DISCLOSED.
17-02-2026
NATIONAL HEALTHCARE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons for change, timing, or any quantitative impacts were provided. No positive or negative metrics, governance implications, or board outcomes were mentioned.
17-02-2026
The company filed an 8-K on February 17, 2026 (AccNo: 0001213900-26-017065) disclosing an officer change or compensatory arrangements of certain officers under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. Specific details on the affected officer's name, title (e.g., CEO, CFO), action (appointment, resignation, retirement), reason, timing, or any related compensation are NOT_DISCLOSED. No quantitative data, financial metrics, performance comparisons, scheduled events, or governance impacts are mentioned in the provided filing information.
17-02-2026
The company filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054205), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for changes, quantitative details, or performance metrics are disclosed in the provided filing information.
17-02-2026
17-02-2026
Goosehead Insurance, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, timing, and any financial metrics are NOT_DISCLOSED.
17-02-2026
Boston Beer Co Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054573), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual involved, reason for change, appointment or resignation status, timing, or any compensatory arrangements are disclosed. No quantitative data, financial metrics, or other changes are mentioned.
17-02-2026
Solaris Energy Infrastructure, Inc. filed an 8-K on 2026-02-17 (AccNo: 0001193125-26-054550) disclosing officer changes under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, effective dates, or quantitative impacts are disclosed.
- ·Filing size: 237 KB
- ·Sector: not specified
17-02-2026
Akamai Technologies Inc filed an 8-K on 2026-02-17 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments of certain officers or directors, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific names, positions affected, reasons for change, or quantitative details provided.
- ·Sector: not specified
- ·Filing Accession Number: 0001086222-26-000004
- ·File Size: 231 KB
17-02-2026
Travelers Companies, Inc. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
17-02-2026
Annexon, Inc. filed a Form 8-K on February 17, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names of individuals, positions affected, reasons for change, timing, or any quantitative compensation data are provided in the filing summary. This is a standard governance disclosure with no additional financial or operational metrics mentioned.
17-02-2026
Quad/Graphics, Inc. filed an 8-K on 2026-02-17 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data are disclosed in the provided filing summary.
17-02-2026
ImageneBio, Inc. filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054684), disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, effective dates, or financial details such as compensation amounts are disclosed in the provided information. No quantitative metrics, performance comparisons, or additional context provided.
17-02-2026
Skillz Inc. filed an 8-K on 2026-02-17 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative data are provided in the filing summary. This appears to be an informational disclosure with no financial metrics or performance comparisons mentioned.
17-02-2026
AMERICAN ELECTRIC POWER CO INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.
17-02-2026
Advanced Micro Devices Inc. filed an 8-K on February 17, 2026 (AccNo: 0000002488-26-000029), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a routine SEC-required disclosure for leadership changes with no additional quantitative or qualitative context provided.
17-02-2026
NorthWestern Energy Group, Inc. filed a Form 8-K on 2026-02-17 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
17-02-2026
Reborn Coffee, Inc. filed a Form 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative data such as compensation amounts are disclosed. Sector is not specified.
17-02-2026
Lithium Americas Corp. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative metrics are provided. This appears to be a routine governance disclosure with no financial or performance data mentioned.
17-02-2026
Falcon's Beyond Global, Inc. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer, position affected, reason for change, or any quantitative impacts are NOT_DISCLOSED.
17-02-2026
ARBOR REALTY TRUST INC filed an 8-K on 2026-02-17 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, names, reasons, or quantitative impacts are disclosed.
17-02-2026
WORLD ACCEPTANCE CORP filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation status, reasons, timing, or any financial metrics are disclosed.
17-02-2026
CBL & Associates Properties Inc filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed.
17-02-2026
MarketAxess Holdings Inc filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-055003), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names of individuals, reasons for the change, effective dates, or any financial metrics are provided. No quantitative data, performance comparisons, or other material impacts are mentioned.
17-02-2026
Carpenter Technology Corp filed an 8-K on February 17, 2026 (AccNo: 0001193125-26-054998, Size: 156 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
17-02-2026
Redwire Corp filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided.
17-02-2026
Dorchester Minerals, L.P. filed an 8-K on 2026-02-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any named individuals are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are provided in the filing summary.
17-02-2026
EXICURE, INC. filed an 8-K on 2026-02-17 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. This is an informational governance event with no additional performance or financial data provided.
17-02-2026
AirJoule Technologies Corp. filed an 8-K on February 17, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or terms are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 51 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings